Smoking Habits and Smoking Cessation in Young Adults

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

September 2, 2016

Conditions
Smoking CessationSmokingHabits
Interventions
DRUG

varenicline

days 1.-3 0,5mgx1/day, days 4.-7 0,5mgx2/day, day 8 to the 12weeks 1mgx2 /day

DRUG

Nicotine cutaneous patch 15mg/16h

One patch for 16hours/day and duration of 8 weeks.

DRUG

Nicotine cutaneous patch 10mg/16h

One patch 16hours/day and duration of 8 weeks

OTHER

Placebo cutaneous patch

No active medication.O ne patch 16hours and duration for 8 weeks

Trial Locations (1)

96400

Lapland Central Hospital, Lapland Hospital District, Rovaniemi

All Listed Sponsors
collaborator

University of Oulu

OTHER

collaborator

University of Helsinki

OTHER

lead

Tuula Toljamo

OTHER

NCT01531049 - Smoking Habits and Smoking Cessation in Young Adults | Biotech Hunter | Biotech Hunter